Slim Fourati
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 19
- SARS-CoV-2 and COVID-19 Research 19
- COVID-19 Clinical Research Studies 11
- Epidemiology 27
- Respiratory viral infections research 10
- Hepatitis B Virus Studies 6
- Co-authors
- Jean–Michel Pawlotsky (30 shared papers)Anne‐Geneviève Marcelin (22 shared papers)Nicolas de Prost (17 shared papers)Christine Katlama (17 shared papers)Christophe Rodriguez (23 shared papers)Vincent Cálvez (21 shared papers)Armand Mekontso Dessap (11 shared papers)Stéphane Chevaliez (13 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (10 papers)Clinical Microbiology and Infection (5 papers)AIDS (5 papers)The Journal of Infectious Diseases (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)
- Partner nations
- FranceUnited StatesMali
In The Last Decade
Slim Fourati
90 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 104
- Virology 308
- Infectious Diseases 801
- Hepatology 195
- Applied Microbiology and Biotechnology 44
- Critical Care and Intensive Care Medicine 80
Countries citing papers authored by Slim Fourati
This map shows the geographic impact of Slim Fourati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Slim Fourati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Slim Fourati more than expected).
Fields of papers citing papers by Slim Fourati
This network shows the impact of papers produced by Slim Fourati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Slim Fourati. The network helps show where Slim Fourati may publish in the future.
Co-authors
The 25 scholars most cited alongside Slim Fourati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 137 | |
| 2 | 2020 | 83 | |
| 3 | 2020 | 83 | |
| 4 | 2018 | 55 | |
| 5 | 2021 | 54 | |
| 6 | 2020 | 53 | |
| 7 | 2018 | 50 | |
| 8 | 2021 | 50 | |
| 9 | 2021 | 50 | |
| 10 | 2014 | 50 | |
| 11 | 2013 | 49 | |
| 12 | 2010 | 48 | |
| 13 | 2015 | 44 | |
| 14 | 2011 | 38 | |
| 15 | 2015 | 38 | |
| 16 | 2012 | 38 | |
| 17 | 2013 | 36 | |
| 18 | 2021 | 34 | |
| 19 | 2021 | 33 | |
| 20 | 2011 | 28 |
About Slim Fourati
Slim Fourati is a scholar working on Infectious Diseases, Epidemiology, Hepatology, Virology and Pulmonary and Respiratory Medicine, having authored 95 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (19 papers), SARS-CoV-2 and COVID-19 Research (19 papers), Hepatitis C virus research (11 papers), COVID-19 Clinical Research Studies (11 papers), Respiratory viral infections research (10 papers), HIV Research and Treatment (9 papers), Hepatitis B Virus Studies (6 papers) and Long-Term Effects of COVID-19 (6 papers). The work is most often cited by research in Virology (308 citations), Infectious Diseases (801 citations), Hepatology (195 citations), Applied Microbiology and Biotechnology (44 citations) and Critical Care and Intensive Care Medicine (80 citations). Slim Fourati has collaborated with scholars based in France, United States and Mali. Frequent co-authors include Jean–Michel Pawlotsky, Anne‐Geneviève Marcelin, Nicolas de Prost, Christine Katlama, Christophe Rodriguez, Vincent Cálvez, Armand Mekontso Dessap, Stéphane Chevaliez, Marc Wirden and Guillaume Carteaux. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection, AIDS, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.